Bugs, Drugs, and HIV: The Role of the Vaginal Microbiome in HIV Risk and Antiretroviral Efficacy for HIV Prevention

Genome Medicine - United Kingdom
doi 10.1186/s13073-017-0469-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

T35: The Virtue of Simplicity: The Vaginal Microbiome, Genital Inflammation and HIV Risk

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2018English

Vaginal Microbicides and the Prevention of HIV Transmission

The Lancet Infectious Diseases
Infectious Diseases
2008English

A Microbiome Variable in the HIV-prevention Equation

Science
MultidisciplinaryPhilosophy of ScienceHistory
2017English

HIV Patients Need New Antiretroviral Drugs

British Medical Journal
Medicine
2005English

Impact of Antiretroviral Drugs on Fracture Risk in HIV-infected Individuals

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2019English

Stigma and HIV Risk Behaviors of Transgender Women in Nepal: Implications for HIV Prevention

Retrovirology
VirologyInfectious Diseases
2010English

Vaginal Formulations for Prevention of Sexual Transmission of HIV

2018English

Antiretroviral-Based HIV-1 Prevention: Antiretroviral Treatment and Pre-Exposure Prophylaxis

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy

Clinical Pharmacology and Therapeutics
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy